Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated: April 2, 2026, 2:50 am
Author: Getaka|Social: XLinkedIn

Dishman Carbogen Amcis Ltd: Intrinsic Value & Share Price Analysis

Fair Value

₹18.45Overvalued by 87.36%vs CMP ₹146.00

P/E (17.4) × ROE (0.3%) × BV (₹406.00) × DY (2.00%)

₹131.11Overvalued by 10.20%vs CMP ₹146.00
MoS: -11.4% (Negative)Confidence: 43/100 (Low)Models: 4 Under, 4 Over
ModelCategoryValueWeightSignal
PE-ROEEarnings₹26.8927%Over (-81.6%)
Graham NumberEarnings₹262.9716%Under (+80.1%)
DCFCash Flow₹22.9813%Over (-84.3%)
Net Asset ValueAssets₹405.639%Under (+177.8%)
EV/EBITDAEnterprise₹225.9111%Under (+54.7%)
Earnings YieldEarnings₹75.709%Over (-48.2%)
ROCE CapitalReturns₹2.849%Over (-98.1%)
Revenue MultipleRevenue₹172.837%Under (+18.4%)
Consensus (8 models)₹131.11100%Overvalued
Key Drivers: EPS CAGR 45.8% lifts DCF — verify sustainability. | ROE 0.3% is below cost of equity.

PE-ROE · Graham · EPV · DCF · NAV · EV/EBITDA · DDM · Earnings Yield · ROCE Capital · Revenue Multiple | CoE: 12% · Terminal: 4% · EPS CAGR: 45.8%

*Investments are subject to market risks

Investment Snapshot

46
Dishman Carbogen Amcis Ltd scores 46/100 (Average)
Based on 5 dimensions: health, institutional flow, earnings quality, momentum, and peer comparison
Stock Health46/100 · Moderate
ROCE 2.4% WeakROE 0.3% WeakD/E 0.18 Low debtInterest Coverage 0.0x RiskyProfitable 2/5 years Inconsistent
Smart Money30/100 · Weak
FII holding down -1.83% (6mo) SellingPromoter holding at 59.3% Stable
Earnings Quality50/100 · Moderate
OPM stable around 14% Steady
Quarterly Momentum50/100 · Moderate
Revenue (4Q): +6% YoY GrowingOPM: 16.0% (down 5.0% YoY) Margin pressure
Industry Rank45/100 · Moderate
P/E 17.4 vs industry 53.8 Cheaper than peersROCE 2.4% vs industry 16.4% Below peersROE 0.3% vs industry 15.2% Below peers3Y sales CAGR: 8% Moderate

Weights: Health 30% · Earnings Quality 25% · Momentum 20% · Industry Rank 15% · Smart Money 10%. Scores are computed from reported financials and recalculated daily. Not investment advice.

Share Price and Basic Stock Data

Last Updated: April 2, 2026, 2:50 am

Market Cap 2,291 Cr.
Current Price 146
Intrinsic Value₹131.11
High / Low 322/128
Stock P/E17.4
Book Value 406
Dividend Yield0.00 %
ROCE2.42 %
ROE0.32 %
Face Value 2.00
PEG Ratio0.38

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for Dishman Carbogen Amcis Ltd

Competitors

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
Dishman Carbogen Amcis Ltd 2,291 Cr. 146 322/12817.4 4060.00 %2.42 %0.32 % 2.00
IOL Chemicals & Pharmaceuticals Ltd 2,273 Cr. 77.4 127/57.518.2 59.71.29 %8.86 %6.13 % 2.00
Bliss GVS Pharma Ltd 2,427 Cr. 229 244/10522.0 1070.22 %11.7 %8.36 % 1.00
Unichem Laboratories Ltd 2,100 Cr. 298 712/27820.0 3460.00 %6.24 %5.59 % 2.00
Morepen Laboratories Ltd 2,038 Cr. 37.2 70.5/33.026.7 21.80.54 %15.1 %11.8 % 2.00
Industry Average19,815.15 Cr1,053.8453.84201.200.39%16.35%15.16%6.10

All Competitor Stocks of Dishman Carbogen Amcis Ltd

Quarterly Result

MetricDec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Sales 640619723587651655524789682716708653720
Expenses 526567602526610592495642542564567504607
Operating Profit 1145112261416329147140153141149113
OPM % 18%8%17%10%6%10%6%19%21%21%20%23%16%
Other Income 4-397564-448-42287
Interest 22242827333132374942434246
Depreciation 50767075808571727279818484
Profit before tax 46-8829-36-66-49-784227283931-10
Tax % -3%-19%42%13%-10%42%0%21%83%-56%39%-114%24%
Net Profit 47-7117-41-60-70-78335432365-13
EPS in Rs 3.00-4.511.08-2.61-3.80-4.46-4.952.110.302.751.494.16-0.83

Last Updated: February 6, 2026, 4:16 am

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: February 23, 2026, 10:46 pm

MetricMar 2011Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Sales 1,0311,7141,6952,0592,0441,9122,1412,4132,6162,7122,797
Expenses 8301,2611,2491,5071,5401,6381,8092,0812,3292,2432,241
Operating Profit 201452445552503274331332286469555
OPM % 20%26%26%27%25%14%15%14%11%17%20%
Other Income 14264654391629-2022433
Interest 5649495762485786120159173
Depreciation 69214211240283308308281311294329
Profit before tax 91216231309197-65-4-55-1221986
Tax % 12%33%33%32%20%154%-524%-45%26%83%
Net Profit 80145155210159-16518-30-1533119
EPS in Rs 9.5813.0310.10-10.531.15-1.90-9.790.217.57
Dividend Payout % 0%0%0%2%0%0%0%0%0%0%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2017-20182018-20192019-20202020-20212021-20222022-20232023-20242024-2025
YoY Net Profit Growth (%)6.90%35.48%-24.29%-203.77%110.91%-266.67%-410.00%101.96%
Change in YoY Net Profit Growth (%)0.00%28.59%-59.77%-179.49%314.68%-377.58%-143.33%511.96%

Dishman Carbogen Amcis Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 8 years from 2017-2018 to 2024-2025.

Growth

Compounded Sales Growth
10 Years:%
5 Years:6%
3 Years:8%
TTM:20%
Compounded Profit Growth
10 Years:%
5 Years:%
3 Years:%
TTM:150%
Stock Price CAGR
10 Years:%
5 Years:7%
3 Years:31%
1 Year:28%
Return on Equity
10 Years:%
5 Years:-1%
3 Years:-1%
Last Year:0%

Last Updated: September 5, 2025, 3:05 am

Balance Sheet

Last Updated: December 10, 2025, 2:36 am

MonthMar 2011Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital 160.00323231313131313131
Reserves 8634,8145,0755,3475,6845,6675,5185,7785,5965,8006,334
Borrowings 8689501,0951,0421,3571,5891,8302,2092,3132,3892,559
Other Liabilities 3348119678991,1211,0681,2551,4211,6311,7662,185
Total Liabilities 2,0816,5747,1697,3218,1938,3568,6349,4399,5719,98711,109
Fixed Assets 1,0124,8525,0665,0985,6785,6985,7736,1886,7247,0557,954
CWIP 3071331511752344867801,043646467309
Investments 1401961671911723242491029791
Other Assets 7611,5501,7571,8812,0912,0001,7581,9592,0982,3682,756
Total Assets 2,0816,5747,1697,3218,1938,3568,6349,4399,5719,98711,109

Reserves and Borrowings Chart

Cash Flow

MonthMar 2011Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Cash from Operating Activity + 203303226282585513355266379375
Cash from Investing Activity + -231-107-297-169-442-380-619-494-225-196
Cash from Financing Activity + 25-13778-102-98-11130250-22-102
Net Cash Flow -35971146122-1332213277
Free Cash Flow -3716422-26177147-101-35276160
CFO/OP 107%92%58%75%131%206%124%90%139%86%

Free Cash Flow

MonthMar 2011Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Free Cash Flow-667.00-498.00444.00551.00502.00273.00330.00330.00284.00467.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2011Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days 606196791038081896890
Inventory Days 272473525496462402526568540655
Days Payable 17295201176226132158155149168
Cash Conversion Cycle 160439419399340350449502458577
Working Capital Days -52354443-10-2-8-37-148-35
ROCE %5%6%4%0%1%1%0%2%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Promoters 59.32%59.32%59.32%59.32%59.32%59.32%59.32%59.32%59.32%59.32%59.32%59.32%
FIIs 9.34%8.90%8.80%8.60%8.70%8.05%8.18%8.75%9.49%9.94%8.07%7.66%
DIIs 2.55%3.13%3.51%3.68%2.36%1.47%1.22%1.42%1.26%1.27%1.37%1.27%
Public 28.79%28.65%28.37%28.39%29.63%31.17%31.29%30.51%29.94%29.48%31.23%31.75%
No. of Shareholders 56,58356,22156,27252,33650,65653,68355,28052,82250,75749,74449,45548,481

Shareholding Pattern Chart

No. of Shareholders

Dishman Carbogen Amcis Ltd: Intrinsic Value & Share Price Analysis - Shareholder trend analysis

Mutual Fund Holdings

Fund NameNo of SharesAUM (%)Amount Invested (Cr)Previous Number of SharesPrevious DatePercentage Change
HSBC Flexi Cap Fund 1,476,000 0.61 32.252,377,0502025-12-07 05:28:48-37.91%

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 25Mar 24Mar 23Mar 22Mar 21
FaceValue 2.002.002.002.002.00
Basic EPS (Rs.) 0.21-9.79-1.901.15-10.53
Diluted EPS (Rs.) 0.21-9.79-1.901.15-10.53
Cash EPS (Rs.) 18.9410.0416.0020.779.11
Book Value[Excl.RevalReserv]/Share (Rs.) 371.91358.90370.51353.89363.44
Book Value[Incl.RevalReserv]/Share (Rs.) 371.91358.90370.51353.89363.44
Revenue From Operations / Share (Rs.) 172.93166.82153.89136.52121.94
PBDIT / Share (Rs.) 31.2920.0722.9623.9019.95
PBIT / Share (Rs.) 12.560.245.054.290.30
PBT / Share (Rs.) 1.23-7.80-3.48-0.27-4.15
Net Profit / Share (Rs.) 0.20-9.79-1.901.15-10.53
NP After MI And SOA / Share (Rs.) 0.20-9.79-1.901.15-10.53
PBDIT Margin (%) 18.0912.0314.9117.5016.35
PBIT Margin (%) 7.260.143.283.130.25
PBT Margin (%) 0.71-4.67-2.26-0.19-3.40
Net Profit Margin (%) 0.11-5.86-1.230.84-8.63
NP After MI And SOA Margin (%) 0.11-5.86-1.230.84-8.63
Return on Networth / Equity (%) 0.05-2.72-0.510.32-2.89
Return on Capital Employeed (%) 2.430.051.030.930.06
Return On Assets (%) 0.03-1.60-0.310.20-1.98
Long Term Debt / Equity (X) 0.190.040.180.130.08
Total Debt / Equity (X) 0.350.340.310.250.18
Asset Turnover Ratio (%) 0.270.270.260.040.03
Current Ratio (X) 1.140.751.071.291.33
Quick Ratio (X) 0.670.400.610.840.91
Inventory Turnover Ratio (X) 3.040.710.860.290.22
Interest Coverage Ratio (X) 3.082.624.206.606.57
Interest Coverage Ratio (Post Tax) (X) 1.13-0.221.211.57-2.00
Enterprise Value (Cr.) 4988.855245.263590.644151.852477.79
EV / Net Operating Revenue (X) 1.842.011.491.941.30
EV / EBITDA (X) 10.1716.679.9711.087.92
MarketCap / Net Operating Revenue (X) 1.261.410.811.360.89
Price / BV (X) 0.580.650.330.520.29
Price / Net Operating Revenue (X) 1.261.410.811.360.89
EarningsYield 0.00-0.04-0.010.01-0.09

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

About the Company - Qualitative Analysis

Dishman Carbogen Amcis Ltd. is a Public Limited Listed company incorporated on 17/07/2007 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is L74900GJ2007PLC051338 and registration number is 051338. Currently Company is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company's Total Operating Revenue is Rs. 399.84 Cr. and Equity Capital is Rs. 31.36 Cr. for the Year ended 31/03/2025.
INDUSTRYADDRESSCONTACT
PharmaceuticalsDishman Corporate House, Ahmedabad Gujarat 380058Contact not found
Management
NamePosition Held
Mr. Arpit J VyasManaging Director
Mrs. Deohooti J VyasWhole Time Director
Mr. Kulin N ShahDirector
Mr. Hemantkumar J BhattDirector
Dr. Margie S ParikhDirector
Mr. Maitri K MehtaIndependent Director
Mr. Rajendra S ShahIndependent Director
Mr. Dhaval R ShahAdditional Director

FAQ

What is the intrinsic value of Dishman Carbogen Amcis Ltd and is it undervalued?

As of 09 April 2026, Dishman Carbogen Amcis Ltd's intrinsic value is ₹131.11, which is 10.20% lower than the current market price of ₹146.00, suggesting the stock is overvalued. This is calculated using the PE ratio method factoring in ROE (0.32 %), book value (₹406), dividend yield (0.00 %), and 5-year EPS CAGR.

What is the current share price and 52-week range of Dishman Carbogen Amcis Ltd?

Dishman Carbogen Amcis Ltd is trading at ₹146.00 as of 09 April 2026, with a FY2026-2027 high of ₹322 and low of ₹128. The stock is currently near its 52-week low. Market cap stands at ₹2,291 Cr..

How does Dishman Carbogen Amcis Ltd's P/E ratio compare to its industry?

Dishman Carbogen Amcis Ltd has a P/E ratio of 17.4, which is below the industry average of 53.84. Trading at a steep discount to peers could signal a value opportunity or reflect concerns about the company's fundamentals.

Is Dishman Carbogen Amcis Ltd financially healthy?

Key indicators for Dishman Carbogen Amcis Ltd: ROCE of 2.42 % is on the lower side compared to the industry average of 16.35%; ROE of 0.32 % is below ideal levels (industry average: 15.16%). Dividend yield is 0.00 %.

Is Dishman Carbogen Amcis Ltd profitable and how is the profit trend?

Dishman Carbogen Amcis Ltd reported a net profit of ₹3 Cr in Mar 2025 on revenue of ₹2,712 Cr. Compared to ₹18 Cr in Mar 2022, the net profit shows a declining trend.

Does Dishman Carbogen Amcis Ltd pay dividends?

Dishman Carbogen Amcis Ltd has a dividend yield of 0.00 % at the current price of ₹146.00. The company is currently not paying meaningful dividends.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Dishman Carbogen Amcis Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE
Explore Industry-wise Stock Analysis Reports